Abstract: The present invention relates to a biotin moiety-conjugated polypeptide and a pharmaceutical composition for oral administration comprising the same, wherein the polypeptide according to the present invention has an excellent in vivo oral bioavailability.

Abstract: The present invention relates to a physiologically active substance to which a biotin moiety is bound; and a composition for oral administration comprising same. A physiologically active substance to which a biotin moiety is bound has excellent oral absorption into the body.

Abstract: The present invention relates to a mini hot press apparatus, and more particularly, to an apparatus which can be used for making or annealing a polycrystalline material by pressurization and heating in various surrounding environments such as in a low vacuum, high vacuum, ultrahigh vacuum, high pressure gas, gas flow, even in air, etc.

Abstract: A method of measuring adhesive strength includes setting an evaluation time (te), fixing a substrate and an adhesive member to a measurement device, pulling the adhesive member fixed to the measurement device with a first measurement force (Fe1) for the evaluation time (te), pulling the adhesive member fixed to the measurement device is pulled with a second measurement force (Fe2), which is obtained by increasing the first measurement force (Fe1) by a preset amount, for the evaluation time (te), and determining a reference measurement force (Fes) which is a static force applied to the adhesive member when a distance by which a first portion of the adhesive member is detached from the substrate is equal to a preset distance (dt) is determined.

Abstract: The present invention relates to a composition for relieving a hangover or a composition for preventing, alleviating or treating alcoholic liver disease, comprising a ?-glucan as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition including a polypeptide, and more particularly, to a pharmaceutical composition for preventing or treating obesity, diabetes, or non-alcoholic fatty liver disease. The pharmaceutical composition is safe without any side effects such as vomiting or nausea, and has effects of reducing food intake, enhancing insulin secretion, suppressing gastric emptying, promoting lipolysis, and lowering a level of triglycerides.

Abstract: The present invention relates to a composition for use in preventing, alleviating, or treating inflammatory disease, or an anti-inflammatory composition, which comprises: ?-1,3-glucan; and the peptide composed of the amino acid sequence of SEQ ID NO: 4. The present invention also relates to an antibacterial composition against bacteria causative of sepsis, which comprises: ?-1,3-glucan; the peptide composed of the amino acid sequence of SEQ ID NO: 4; and an antibiotic. The present invention also relates to a method for preventing or treating an inflammatory disease, the method comprising a step of administering ?-1,3-glucan; and the peptide composed of the amino acid sequence of SEQ ID NO: 4 to a patient.

Abstract: The present invention relates to a pharmaceutical composition for treating a wound or activating the skin, containing beta-glucan, glycitin (4?-hydroxy-6-methoxyisoflavone-7-D-glucoside), and 4?,6,7-trimethoxyisoflavone.

Abstract: A display device including a pixel comprises an EVDD driving unit outputting an AC driving voltage swinging between a high potential voltage and a low potential voltage according to voltages of a first control node and a second control node, and a plurality of sub-pixels connected to a data line and a gate line to receive the AC driving voltage by sharing an output node of the EVDD driving unit. Each of the sub-pixels may include a light emitting element, a driving element for supplying a current to the light emitting element according to a gate-source voltage, a switch element turned-on according to a scan signal to connect the data line to the gate of the driving element, and a capacitor connected between a gate and a source of the driving element.